BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9475144)

  • 21. Gestatational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease.
    Kani KK; Lee JH; Dighe M; Moshiri M; Kolokythas O; Dubinsky T
    Curr Probl Diagn Radiol; 2012; 41(1):1-10. PubMed ID: 22085657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia.
    Garavaglia E; Gentile C; Cavoretto P; Spagnolo D; Valsecchi L; Mangili G
    Am J Obstet Gynecol; 2009 Apr; 200(4):417.e1-5. PubMed ID: 19200936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic image (28). Hydatidiform mole].
    Blaauwgeers JL; Bais JM
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):477. PubMed ID: 11268910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced dynamic MR imaging of postmolar gestational trophoblastic disease.
    Yamashita Y; Torashima M; Takahashi M; Mizutani H; Miyazaki K; Matsuura K; Okamura H
    Acta Radiol; 1995 Mar; 36(2):188-92. PubMed ID: 7536014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of combined use of ultrasonography and beta-hCG determination in diagnosis of pelvic lesions of malignant trophoblastic disease].
    Fu QZ; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):352-4, 383-4. PubMed ID: 2178083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria toward the definition of nonmetastatic gestational trophoblastic disease after hydatidiform mole.
    Kohorn EI
    Am J Obstet Gynecol; 1982 Feb; 142(4):416-9. PubMed ID: 6277194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hysteroscopy provides proof of trophoblastic tumors in three cases with negative color Doppler images.
    Lindholm H; Rådestad A; Flam F
    Ultrasound Obstet Gynecol; 1997 Jan; 9(1):59-61. PubMed ID: 9060133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current clinical features of complete and partial hydatidiform mole in Sweden.
    Joneborg U; Marions L
    J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestational trophoblastic disease: a spectrum of radiologic diagnosis.
    Green CL; Angtuaco TL; Shah HR; Parmley TH
    Radiographics; 1996 Nov; 16(6):1371-84. PubMed ID: 8946542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation and management of molar pregnancy.
    Sasaki S
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):885-92. PubMed ID: 14614887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of gestational trophoblastic disease: value of endovaginal color flow Doppler sonography.
    Desai RK; Desberg AL
    AJR Am J Roentgenol; 1991 Oct; 157(4):787-8. PubMed ID: 1892037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.